Literature DB >> 23197265

Cataract surgery in patients with corneal disease.

Jonathan B Greene1, Shahzad I Mian.   

Abstract

PURPOSE OF REVIEW: Preexisting corneal disease can be exacerbated by cataract surgery and may prevent well tolerated cataract extraction. This article reviews the current literature and describes how corneal epithelial, stromal and endothelial disease may impact and be impacted by cataract surgery while highlighting recommendations for perioperative management and surgical technique. RECENT
FINDINGS: Modifications to surgical techniques can allow for improved intraoperative visualization and safer cataract removal. Cataract surgery can be safely performed in conjunction with newer forms of corneal transplantation such as deep anterior lamellar keratoplasty and endothelial keratoplasty; however, guidelines for when to perform combined surgery have not been established.
SUMMARY: Appropriate perioperative management and advances in surgical techniques and technologies allow for successful cataract surgery in patients with corneal disease. Signs of corneal disease should be identified preoperatively to allow for surgical planning and optimal visual outcomes.

Entities:  

Mesh:

Year:  2013        PMID: 23197265     DOI: 10.1097/ICU.0b013e32835aeec4

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  3 in total

1.  Deep anterior lamellar keratoplasty--triple procedure: a useful clinical application of the pre-Descemet's layer (Dua's layer).

Authors:  A A Zaki; M S Elalfy; D G Said; H S Dua
Journal:  Eye (Lond)       Date:  2014-10-31       Impact factor: 3.775

2.  Preoperative evaluation of human crystalline lens hardness using A-scan ultrasound biometry: a pilot study.

Authors:  Konstantinos T Tsaousis; Lampros P Lamprogiannis; Stavros A Dimitrakos; Ioannis T Tsinopoulos
Journal:  Int J Ophthalmol       Date:  2016-10-18       Impact factor: 1.779

3.  Cataract surgery in patients with corneal opacities.

Authors:  Yi-Ju Ho; Chi-Chin Sun; Hung-Chi Chen
Journal:  BMC Ophthalmol       Date:  2018-04-23       Impact factor: 2.209

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.